2019
DOI: 10.1016/j.hpb.2019.10.1517
|View full text |Cite
|
Sign up to set email alerts
|

Modeling early genomic events of pancreatic cancer using CRISPR/Cas9

Abstract: were observed (p=0.09). Harvested lymph nodes were 16 and 17 for LPD and OPD (p=0.67). Length of stay was 14 and 16 days for LPD and OPD groups (p=0.25). Conclusion: Preliminary results show that LPD is safe and feasible, although high conversion rate when done in nonselected patients. No differences in clinical outcomes were observed between approaches.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles